Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Current Leases (2023 - 2024)

Neuroone Medical Technologies' Current Leases history spans 2 years, with the latest figure at $65768.0 for Q3 2024.

  • For Q3 2024, Current Leases fell 49.06% year-over-year to $65768.0; the TTM value through Sep 2024 reached $65768.0, down 49.06%, while the annual FY2024 figure was $65768.0, 49.06% down from the prior year.
  • Current Leases reached $65768.0 in Q3 2024 per NMTC's latest filing, down from $129116.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $129116.0 in Q3 2023 to a low of $65768.0 in Q3 2024.